Segmentation, Major Trends, and Competitive Overview of the Point of Care Hematology Diagnostics Market

The point of care hematology diagnostics market is on track for substantial expansion over the coming years. Driven by evolving healthcare needs and technological innovation, this sector is set to offer critical solutions for faster and more accessible blood testing outside traditional laboratory settings. Let's explore the market's projected growth, leading companies, trends influencing its trajectory, and the key segments shaping its future.

Forecasted Growth and Market Size of the Point Of Care Hematology Diagnostics Market
The global point of care hematology diagnostics market is anticipated to reach a valuation of $4.39 billion by 2030. This reflects a strong compound annual growth rate (CAGR) of 8.6% during the forecast period. Several factors are contributing to this robust growth, including the increasing incidence of chronic and infectious diseases worldwide. Additionally, there is a notable expansion in point of care testing programs and a rising demand for rapid diagnostic solutions, especially in emergency care settings. Advancements in compact hematology analyzers and the broader adoption of decentralized healthcare delivery models are also fueling market growth. Key trends expected to impact this market include the growing use of rapid bedside blood testing and the rising demand for portable and handheld hematology devices. Furthermore, there is intensified focus on expanding point of care testing in resource-limited regions and delivering faster clinical decision-making turnaround times.

Download a free sample of the point of care hematology diagnostics market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-hematology-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Drivers Behind the Expansion of the Point Of Care Hematology Diagnostics Market
A key factor accelerating the market is the growing prevalence of chronic and infectious diseases, which necessitates timely and accurate diagnosis. Healthcare providers are increasingly prioritizing point of care hematology testing due to its ability to deliver quick results, which is critical in emergency and critical care scenarios.
Another important driver is the advancement in technology related to portable and compact hematology analyzers. These innovations allow diagnostics to be conducted effectively outside traditional labs, supporting decentralized healthcare models and increasing accessibility in remote or resource-constrained areas.

Prominent Players Influencing the Point Of Care Hematology Diagnostics Industry
Several industry leaders hold significant positions in this market. These include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton dic*kinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, and Bio-Rad Laboratories Inc.
A notable recent development took place in June 2023 when Mars Inc., a US-based pet care company, acquired Heska Corporation. This move aims to boost Mars' veterinary diagnostics offerings and strengthen its foothold in advanced animal healthcare through Heska's innovative point of care hematology diagnostics solutions.

View the full point of care hematology diagnostics market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-hematology-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

How Recent Trends Are Impacting the Point Of Care Hematology Diagnostics Market
Mars Inc.'s acquisition of Heska Corporation highlights the strategic importance of expanding point of care hematology capabilities, especially in veterinary diagnostics. This consolidation is expected to enhance the availability and sophistication of POC hematology tests in animal healthcare.
Additionally, there is a growing trend of adopting portable, handheld hematology devices that offer rapid and reliable results. The shift toward decentralized diagnostics continues to increase, particularly in urgent care and emergency settings where quick decision-making is vital to patient outcomes.

Breakdown of Market Segments Covered in the Point Of Care Hematology Diagnostics Industry
The market is analyzed across several key segments to provide a comprehensive understanding:
1) By Type: including Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, and Other Types.
2) By Mode of Prescription: categorized as Prescription Based Products and Over-The-Counter Based Products.
3) By End User: consisting of Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, and Other End Users.

Further detailed subsegments include:
- Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, and Mean Corpuscular Volume (MCV).
- Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, and Fibrinogen Level.
- Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, and Methemoglobin.
- Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, and Transferrin Saturation.
- Other Types: Blood Typing and Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, and C-Reactive Protein Testing.

This detailed segmentation allows stakeholders to gain deeper insights into specific areas of focus and emerging opportunities within the point of care hematology diagnostics market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.